Amit D. Tevar
University of Pittsburgh
113 Papers
250 Citations
Amit D. Tevar is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Medicine & Transplantation. The author has an hindex of 23, co-authored 95 publications. Previous affiliations of Amit D. Tevar include University of Cincinnati Academic Health Center & University of Cincinnati.
Chat about Author
Papers
Reducing De Novo Donor‐Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss
Matthew J Everly,J. J. Everly,Lois J. Arend,Paul Brailey,Brian Susskind,Amit Govil,A.H. Rike,Prabir Roy-Chaudhury,G. Mogilishetty,Rita R. Alloway,Amit D. Tevar,E. S. Woodle +11 more
TL;DR: De novo DSAs detected at rejection are associated with reduced allograft survival, but prompt DSA reduction was associated with improved allografted survival, and DSA should be considered a potential new end point for rejection therapy.
213
Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
Abhinav Humar,Swaytha Ganesh,Dana R. Jorgensen,Amit D. Tevar,Armando Ganoza,Michele Molinari,Christopher Hughes +6 more
TL;DR: In this paper, the authors compared outcomes between living donor liver transplant (LDLT) and deceased donor transplant (DDLT) at a single center to demonstrate the advantages of LDLT and provide justification for the increased utilization and application of this procedure.
136
Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice.
Nozomu Sakai,Heather L. Van Sweringen,R. Cutler Quillin,Rebecca Schuster,John Blanchard,Justin M. Burns,Amit D. Tevar,Michael J. Edwards,Alex B. Lentsch +8 more
TL;DR: It appears that IL‐33 has direct protective effects on hepatocytes, associated with the activation of NF‐κB, p38 MAPK, cyclin D1, and Bcl‐2 that limits liver injury and reduces the stimulus for inflammation.
97
CXC chemokine signaling in the liver: impact on repair and regeneration.
Heather L. Van Sweringen,Nozomu Sakai,Amit D. Tevar,Justin M. Burns,Michael J. Edwards,Alex B. Lentsch +5 more
TL;DR: The current understanding of the pathways involved in both CXC chemokine receptor signaling in other cell types, most notably neutrophils, and similar pathways operant during hepatocyte proliferation/liver regeneration are reviewed to formulate a basis for the function of CXCs chemokines receptor signaled in hepatocytes.
67
Proteasome Inhibition Reduces Donor-Specific Antibody Levels
Matthew J Everly,J. J. Everly,B. Susskind,Paul Brailey,Lois J. Arend,Rita R. Alloway,Prabir Roy-Chaudhury,Amit Govil,G. Mogilishetty,A.H. Rike,M. Cardi,G Wadih,Evan A. Brown,Amit D. Tevar,E. S. Woodle +14 more
- 01 Jan 2009
TL;DR: Preliminary results indicate that proteasome inhibition provides an effective means for reducing HLA antibody levels in transplant recipients with long-term suppression with bortezomib.
63